Literature DB >> 31736240

Rare SUZ12 variants commonly cause an overgrowth phenotype.

Sharri S Cyrus1,2, Ana S A Cohen1,2, Ruky Agbahovbe1,2, Kristiina Avela3, Kit S Yeung4, Brian H Y Chung4, Ho-Ming Luk5, Nataliya Tkachenko6, Sanaa Choufani7, Rosanna Weksberg7,8,9, Elena Lopez-Rangel10, Kathleen Brown11, Margarita S Saenz11, Shayna Svihovec11, Shawn E McCandless11, Lynne M Bird12,13, Aixa Gonzalez Garcia14, Michael J Gambello14, Kirsty McWalter15, Rhonda E Schnur15, Jianghong An16,17, Steven J M Jones1,16,17,18, Sanjiv K Bhalla19,20, Hailey Pinz21, Stephen R Braddock21, William T Gibson1,2.   

Abstract

The Polycomb repressive complex 2 is an epigenetic writer and recruiter with a role in transcriptional silencing. Constitutional pathogenic variants in its component proteins have been found to cause two established overgrowth syndromes: Weaver syndrome (EZH2-related overgrowth) and Cohen-Gibson syndrome (EED-related overgrowth). Imagawa et al. (2017) initially reported a singleton female with a Weaver-like phenotype with a rare coding SUZ12 variant-the same group subsequently reported two additional affected patients. Here we describe a further 10 patients (from nine families) with rare heterozygous SUZ12 variants who present with a Weaver-like phenotype. We report four frameshift, two missense, one nonsense, and two splice site variants. The affected patients demonstrate variable pre- and postnatal overgrowth, dysmorphic features, musculoskeletal abnormalities and developmental delay/intellectual disability. Some patients have genitourinary and structural brain abnormalities, and there may be an association with respiratory issues. The addition of these 10 patients makes a compelling argument that rare pathogenic SUZ12 variants frequently cause overgrowth, physical abnormalities, and abnormal neurodevelopmental outcomes in the heterozygous state. Pathogenic SUZ12 variants may be de novo or inherited, and are sometimes inherited from a mildly-affected parent. Larger samples sizes will be needed to elucidate whether one or more clinically-recognizable syndromes emerge from different variant subtypes.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990SUZ12; Cohen-Gibson syndrome; Polycomb repressive complex 2; SUZ12-related overgrowth; Weaver syndrome

Mesh:

Substances:

Year:  2019        PMID: 31736240     DOI: 10.1002/ajmg.c.31748

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  8 in total

Review 1.  Regulation, functions and transmission of bivalent chromatin during mammalian development.

Authors:  Trisha A Macrae; Julie Fothergill-Robinson; Miguel Ramalho-Santos
Journal:  Nat Rev Mol Cell Biol       Date:  2022-08-26       Impact factor: 113.915

Review 2.  The interplay between DNA and histone methylation: molecular mechanisms and disease implications.

Authors:  Yinglu Li; Xiao Chen; Chao Lu
Journal:  EMBO Rep       Date:  2021-04-12       Impact factor: 8.807

Review 3.  Atypical NF1 Microdeletions: Challenges and Opportunities for Genotype/Phenotype Correlations in Patients with Large NF1 Deletions.

Authors:  Hildegard Kehrer-Sawatzki; Ute Wahlländer; David N Cooper; Victor-Felix Mautner
Journal:  Genes (Basel)       Date:  2021-10-19       Impact factor: 4.096

Review 4.  Classification of NF1 microdeletions and its importance for establishing genotype/phenotype correlations in patients with NF1 microdeletions.

Authors:  Hildegard Kehrer-Sawatzki; David N Cooper
Journal:  Hum Genet       Date:  2021-09-18       Impact factor: 4.132

5.  Hmga2 protein loss alters nuclear envelope and 3D chromatin structure.

Authors:  Giuseppina Divisato; Andrea M Chiariello; Andrea Esposito; Pietro Zoppoli; Federico Zambelli; Maria Antonietta Elia; Graziano Pesole; Danny Incarnato; Fabiana Passaro; Silvia Piscitelli; Salvatore Oliviero; Mario Nicodemi; Silvia Parisi; Tommaso Russo
Journal:  BMC Biol       Date:  2022-08-02       Impact factor: 7.364

6.  DNA Methylation Signature for EZH2 Functionally Classifies Sequence Variants in Three PRC2 Complex Genes.

Authors:  Sanaa Choufani; William T Gibson; Andrei L Turinsky; Brian H Y Chung; Tianren Wang; Kopal Garg; Alessandro Vitriolo; Ana S A Cohen; Sharri Cyrus; Sarah Goodman; Eric Chater-Diehl; Jack Brzezinski; Michael Brudno; Luk Ho Ming; Susan M White; Sally Ann Lynch; Carol Clericuzio; I Karen Temple; Frances Flinter; Vivienne McConnell; Tom Cushing; Lynne M Bird; Miranda Splitt; Bronwyn Kerr; Stephen W Scherer; Jerry Machado; Eri Imagawa; Nobuhiko Okamoto; Naomichi Matsumoto; Guiseppe Testa; Maria Iascone; Romano Tenconi; Oana Caluseriu; Roberto Mendoza-Londono; David Chitayat; Cheryl Cytrynbaum; Katrina Tatton-Brown; Rosanna Weksberg
Journal:  Am J Hum Genet       Date:  2020-04-02       Impact factor: 11.025

Review 7.  Overgrowth Syndromes-Evaluation, Diagnosis, and Management.

Authors:  Joshua Manor; Seema R Lalani
Journal:  Front Pediatr       Date:  2020-10-30       Impact factor: 3.418

Review 8.  Reciprocal skeletal phenotypes of PRC2-related overgrowth and Rubinstein-Taybi syndromes: potential role of H3K27 modifications.

Authors:  Daniel Gamu; William T Gibson
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-08-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.